BRITEBIO, INC.
Biotech · Private
High-throughput human cell-based toxicological screening platform using endothelial progenitor cells (ECFCs) to assess chemical toxicant effects on human development
- Grants
- $1.5M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Endothelial Progenitor Cells for Assessing Toxicological Response Variability in Humans | $474,276 | |
| Federal grant | Department of Health and Human Services · Phase II · Endothelial Progenitor Cells for Assessing Toxicological Response Variability in Humans | $308,656 | |
| Federal grant | Department of Health and Human Services · Phase II · Endothelial Progenitor Cells for Assessing Toxicological Response Variability in Humans | $717,067 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1505 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | — | — |
| 1506 | VLP BIOTECH, INC. | — | — |
| 1507 | KINASENSE, LLC | — | — |
| 1508 | BRITEBIO, INC. | — | — |
| 1509 | MARROWSOURCE THERAPEUTICS INTERNATIONAL | — | — |
| 1510 | Inscripta | — | $450M |
| 1511 | Mirador Therapeutics | — | $413M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.